These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 25902842)

  • 61. Home treatment with intravenous enzyme replacement therapy with idursulfase for mucopolysaccharidosis type II - data from the Hunter Outcome Survey.
    Burton BK; Guffon N; Roberts J; van der Ploeg AT; Jones SA;
    Mol Genet Metab; 2010; 101(2-3):123-9. PubMed ID: 20638311
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Clinical investigator perspectives on patient outcomes in children with neuronopathic mucopolysaccharidosis II during intrathecal idursulfase-IT treatment.
    Yee KS; Alexanderian D; Martin S; Olayinka-Amao B; Whiteman DAH
    Orphanet J Rare Dis; 2024 Apr; 19(1):158. PubMed ID: 38610004
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Parental experience of enzyme replacement therapy for Hunter syndrome.
    Buraczewska M; O'Leary D; Walsh O; Monavari A; Crushell E
    Ir Med J; 2013 Apr; 106(4):120-2. PubMed ID: 23691848
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Impact of enzyme replacement therapy on linear growth in Korean patients with mucopolysaccharidosis type II (Hunter syndrome).
    Cho SY; Huh R; Chang MS; Lee J; Kwun Y; Maeng SH; Kim SJ; Sohn YB; Park SW; Kwon EK; Han SJ; Jung J; Jin DK
    J Korean Med Sci; 2014 Feb; 29(2):254-60. PubMed ID: 24550654
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Mucopolysaccharidosis type II, Hunter's syndrome.
    Tylki-Szymańska A
    Pediatr Endocrinol Rev; 2014 Sep; 12 Suppl 1():107-13. PubMed ID: 25345092
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Hunter syndrome in an 11-year old girl on enzyme replacement therapy with idursulfase: brain magnetic resonance imaging features and evolution.
    Manara R; Rampazzo A; Cananzi M; Salviati L; Mardari R; Drigo P; Tomanin R; Gasparotto N; Priante E; Scarpa M
    J Inherit Metab Dis; 2010 Dec; 33 Suppl 3():S67-72. PubMed ID: 20052546
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Iduronate-2-Sulfatase with Anti-human Transferrin Receptor Antibody for Neuropathic Mucopolysaccharidosis II: A Phase 1/2 Trial.
    Okuyama T; Eto Y; Sakai N; Minami K; Yamamoto T; Sonoda H; Yamaoka M; Tachibana K; Hirato T; Sato Y
    Mol Ther; 2019 Feb; 27(2):456-464. PubMed ID: 30595526
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Long-term enzyme replacement therapy in a severe case of mucopolysaccharidosis type II (Hunter syndrome).
    Papadia F; Lozupone MS; Gaeta A; Capodiferro D; Lacalendola G
    Eur Rev Med Pharmacol Sci; 2011 Mar; 15(3):253-8. PubMed ID: 21528770
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Mucopolysaccharidosis Type II (Hunter Syndrome): clinical picture and treatment.
    Beck M
    Curr Pharm Biotechnol; 2011 Jun; 12(6):861-6. PubMed ID: 21235446
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Safety evaluation of chronic intrathecal administration of idursulfase-IT in cynomolgus monkeys.
    Felice BR; Wright TL; Boyd RB; Butt MT; Pfeifer RW; Pan J; Ruiz JA; Heartlein MW; Calias P
    Toxicol Pathol; 2011 Aug; 39(5):879-92. PubMed ID: 21628718
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Idursulfase: I2S, iduronato-2-sulfatase.
    Drugs R D; 2006; 7(4):254-8. PubMed ID: 16784250
    [No Abstract]   [Full Text] [Related]  

  • 72. Ten years of the Hunter Outcome Survey (HOS): insights, achievements, and lessons learned from a global patient registry.
    Muenzer J; Jones SA; Tylki-Szymańska A; Harmatz P; Mendelsohn NJ; Guffon N; Giugliani R; Burton BK; Scarpa M; Beck M; Jangelind Y; Hernberg-Stahl E; Larsen MP; Pulles T; Whiteman DAH
    Orphanet J Rare Dis; 2017 May; 12(1):82. PubMed ID: 28464912
    [TBL] [Abstract][Full Text] [Related]  

  • 73. First treatment for Hunter syndrome.
    FDA Consum; 2006; 40(6):5. PubMed ID: 17333554
    [No Abstract]   [Full Text] [Related]  

  • 74. The effect of idursulfase on growth in patients with Hunter syndrome: data from the Hunter Outcome Survey (HOS).
    Jones SA; Parini R; Harmatz P; Giugliani R; Fang J; Mendelsohn NJ;
    Mol Genet Metab; 2013 May; 109(1):41-8. PubMed ID: 23537841
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A biochemical and physicochemical comparison of two recombinant enzymes used for enzyme replacement therapies of hunter syndrome.
    Chung YK; Sohn YB; Sohn JM; Lee J; Chang MS; Kwun Y; Kim CH; Lee JY; Yook YJ; Ko AR; Jin DK
    Glycoconj J; 2014 May; 31(4):309-15. PubMed ID: 24781369
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effects of enzyme replacement therapy on growth in patients with mucopolysaccharidosis type II.
    Schulze-Frenking G; Jones SA; Roberts J; Beck M; Wraith JE
    J Inherit Metab Dis; 2011 Feb; 34(1):203-8. PubMed ID: 20978944
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Expanding the phenotype of mucopolysaccharidosis type II retinopathy.
    Kowalski T; Ruddle JB; de Jong G; Mack HG
    Ophthalmic Genet; 2021 Oct; 42(5):631-636. PubMed ID: 34251974
    [No Abstract]   [Full Text] [Related]  

  • 78. Analysis of long-term observations of the large group of Russian patients with Hunter syndrome (mucopolysaccharidosis type II).
    Semyachkina AN; Voskoboeva EY; Nikolaeva EA; Zakharova EY
    BMC Med Genomics; 2021 Mar; 14(1):71. PubMed ID: 33676511
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Glycosaminoglycans can be associated with oxidative damage in mucopolysaccharidosis II patients submitted to enzyme replacement therapy.
    Negretto GW; Deon M; Biancini GB; Burin MG; Giugliani R; Vargas CR
    Cell Biol Toxicol; 2014 Aug; 30(4):189-93. PubMed ID: 25022704
    [No Abstract]   [Full Text] [Related]  

  • 80. The role of enzyme replacement therapy in severe Hunter syndrome-an expert panel consensus.
    Muenzer J; Bodamer O; Burton B; Clarke L; Frenking GS; Giugliani R; Jones S; Rojas MV; Scarpa M; Beck M; Harmatz P
    Eur J Pediatr; 2012 Jan; 171(1):181-8. PubMed ID: 22037758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.